Delivery Order W911QY08D0021-0002

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a nonprofit research organization. The contract is for the "Identification of Lead Compounds to Inhibit HIV-1 Regulatory Proteins" and has a ceiling value of $516,565. This is a cost-plus-fixed-fee delivery order contract, without a set-aside designation. Southern Research Institute holds...

Southern Research Institute was awarded a $749,998 cost-plus-fixed-fee delivery order against the In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides contract vehicle by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS). Under this delivery order, Southern Research will carry out activities to optimize, develop, and synthesize lead anti-HIV candidates and analogs, including resynthesis, acquisition, or...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $496,282.56 cost-plus-fixed-fee contract was awarded to Southern Research Institute to identify anti-HIV therapeutics and topical microbicides through in vitro testing. The contract is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program and does not have a...

Southern Research Institute, a non-profit biomedical research organization based in Birmingham, Alabama, has received a delivery order valued at $403,478 under the National Institute of Allergy and Infectious Diseases (NIAID) "Preclinical Services for HIV Therapeutics" Indefinite Delivery/Indefinite Quantity (IDIQ) master contract. The delivery order, awarded on September 1, 2023, with an ultimate completion date of August 31, 2026, tasks Southern Research with conducting hit-to-lead...

Leidos Biomedical Research Inc., a Federally Funded Research and Development Center contractor, received a $9.2 million delivery order from the National Institute of Allergy and Infectious Diseases (NIAID) under a cost-plus-fixed-fee contract type to complete HIV studies intended to describe the characteristics, course, and treatment response of HIV disease in the study population. The award, issued on September 30, 2019, with an ultimate completion date of March 31, 2026, is being performed...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $3.78M to Advanced Bioscience Laboratories, Inc. (ABL) on August 31, 2024, for feasibility studies on developing a liposome/lipid nanoparticle (LNP) displaying an HIV envelope trimer protein and incorporating messenger RNA (mRNA). The contract, which extends through August 27, 2028, operates under a cost-plus-fixed-fee pricing structure with no set-aside designation. Work will be performed at...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Southern Research Institute on July 26, 2018, with a ceiling value of $99,998.00 under a cost-plus-fixed-fee pricing structure. The order requires acquisition and storage of chemical compound libraries and high-throughput screening of interventional agents to identify and characterize at least one agent with activity to block HIV infection, inhibit HIV gene expression and replication, or cure infected cells of...

This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...